Ototoxicity of aminoglucoside antibiotics in long-term treatment for cystic fibrosis.
D000293:Adolescent; D000328:Adult; D000617:Aminoglycosides / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000188:drug therapy*; D005839:Gentamicins / Q000009:adverse effects; D034381:Hearing Loss / Q000139:chemically induced*; D006314:Hearing Loss, Conductive / Q000139:chemically induced*; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced*; D006801:Humans; D008134:Long-Term Care; D014031:Tobramycin / Q000009:adverse effects
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D005839:Gentamicins; D014031:Tobramycin